{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:31:50Z","timestamp":1793089910238,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00520-013-1767-x","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T05:55:39Z","timestamp":1361944539000},"page":"2097-2106","source":"Crossref","is-referenced-by-count":12,"title":["Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Masatoshi","family":"Inagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Akechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Uchitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"issue":"1","key":"1767_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SC Teunissen","year":"2007","unstructured":"Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34(1):94\u2013104. doi: 10.1016\/j.jpainsymman.2006.10.015","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1767_CR2","first-page":"465","volume":"28","author":"MJ Dodd","year":"2001","unstructured":"Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465\u2013470","journal-title":"Oncol Nurs Forum"},{"issue":"5","key":"1767_CR3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0885-3924(96)00181-9","volume":"12","author":"L Grassi","year":"1996","unstructured":"Grassi L, Indelli M, Marzola M, Maestri A, Santini A, Piva E, Boccalon M (1996) Depressive symptoms and quality of life in home-care-assisted cancer patients. J Pain Symptom Manage 12(5):300\u2013307","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"1767_CR4","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1188\/06.ONF.E79-E89","volume":"33","author":"C Miaskowski","year":"2006","unstructured":"Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, West C, Cho M, Bank A (2006) Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 33(5):E79\u2013E89. doi: 10.1188\/06.ONF.E79-E89","journal-title":"Oncol Nurs Forum"},{"issue":"5","key":"1767_CR5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0885-3924(99)00008-1","volume":"17","author":"C Miaskowski","year":"1999","unstructured":"Miaskowski C, Lee KA (1999) Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 17(5):320\u2013332","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"1767_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/082585979401000211","volume":"10","author":"NI Cherny","year":"1994","unstructured":"Cherny NI, Coyle N, Foley KM (1994) Suffering in the advanced cancer patient: a definition and taxonomy. J Palliat Care 10(2):57\u201370","journal-title":"J Palliat Care"},{"issue":"1","key":"1767_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.11890","volume":"100","author":"T Akechi","year":"2004","unstructured":"Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y (2004) Suicidality in terminally ill Japanese patients with cancer. Cancer 100(1):183\u2013191. doi: 10.1002\/cncr.11890","journal-title":"Cancer"},{"issue":"22","key":"1767_CR8","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1001\/jama.284.22.2907","volume":"284","author":"W Breitbart","year":"2000","unstructured":"Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, Nelson CJ, Brescia R (2000) Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. Jama 284(22):2907\u20132911","journal-title":"Jama"},{"issue":"2","key":"1767_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1176\/ajp.143.2.208","volume":"143","author":"JH Brown","year":"1986","unstructured":"Brown JH, Henteleff P, Barakat S, Rowe CJ (1986) Is it normal for terminally ill patients to desire death? Am J Psychiatry 143(2):208\u2013211","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1767_CR10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1176\/ajp.152.8.1185","volume":"152","author":"HM Chochinov","year":"1995","unstructured":"Chochinov HM, Wilson KG, Enns M, Mowchun N, Lander S, Levitt M, Clinch JJ (1995) Desire for death in the terminally ill. Am J Psychiatry 152(8):1185\u20131191","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"1767_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-0327(95)00047-X","volume":"36","author":"MM Henriksson","year":"1995","unstructured":"Henriksson MM, Isometsa ET, Hietanen PS, Aro HM, Lonnqvist JK (1995) Mental disorders in cancer suicides. J Affect Disord 36(1\u20132):11\u201320","journal-title":"J Affect Disord"},{"issue":"5","key":"1767_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpainsymman.2004.02.017","volume":"28","author":"T Morita","year":"2004","unstructured":"Morita T (2004) Palliative sedation to relieve psycho-existential suffering of terminally ill cancer patients. J Pain Symptom Manage 28(5):445\u2013450. doi: 10.1016\/j.jpainsymman.2004.02.017","journal-title":"J Pain Symptom Manage"},{"issue":"15","key":"1767_CR13","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/djg014","volume":"95","author":"DL Patrick","year":"2003","unstructured":"Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Ried LD, Turrisi AT 3rd, Unutzer J, Vernon SW (2003) National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15\u201317, 2002. J Natl Cancer Inst 95(15):1110\u20131117","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"1767_CR14","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0889-1591(02)00078-8","volume":"17","author":"L Capuron","year":"2003","unstructured":"Capuron L, Dantzer R (2003) Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17(Suppl 1):S119\u2013S124","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1767_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","volume":"105","author":"SF Maier","year":"1998","unstructured":"Maier SF, Watkins LR (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105(1):83\u2013107","journal-title":"Psychol Rev"},{"issue":"1\u20133","key":"1767_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jad.2009.02.017","volume":"119","author":"L Capuron","year":"2009","unstructured":"Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH (2009) Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord 119(1\u20133):181\u2013185. doi: 10.1016\/j.jad.2009.02.017","journal-title":"J Affect Disord"},{"issue":"1","key":"1767_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46\u201356. doi: 10.1038\/nrn2297","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"1767_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH (2002) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26(5):643\u2013652. doi: 10.1016\/S0893-133X(01)00407-9","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"1767_CR19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1200\/JCO.2010.30.7173","volume":"29","author":"H Seow","year":"2011","unstructured":"Seow H, Barbera L, Sutradhar R, Howell D, Dudgeon D, Atzema C, Liu Y, Husain A, Sussman J, Earle C (2011) Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol 29(9):1151\u20131158. doi: 10.1200\/JCO.2010.30.7173","journal-title":"J Clin Oncol"},{"issue":"2","key":"1767_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171\u2013186. doi: 10.1097\/PSY.0b013e3181907c1b","journal-title":"Psychosom Med"},{"issue":"5","key":"1767_CR21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446\u2013457. doi: 10.1016\/j.biopsych.2009.09.033","journal-title":"Biol Psychiatry"},{"issue":"11","key":"1767_CR22","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/cncr.22294","volume":"107","author":"CF Jehn","year":"2006","unstructured":"Jehn CF, Kuehnhardt D, Bartholomae A, Pfeiffer S, Krebs M, Regierer AC, Schmid P, Possinger K, Flath BC (2006) Biomarkers of depression in cancer patients. Cancer 107(11):2723\u20132729. doi: 10.1002\/cncr.22294","journal-title":"Cancer"},{"issue":"8","key":"1767_CR23","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","volume":"158","author":"DL Musselman","year":"2001","unstructured":"Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158(8):1252\u20131257","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1767_CR24","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.pnpbp.2007.05.001","volume":"31","author":"H Soygur","year":"2007","unstructured":"Soygur H, Palaoglu O, Akarsu ES, Cankurtaran ES, Ozalp E, Turhan L, Ayhan IH (2007) Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31(6):1242\u20131247. doi: 10.1016\/j.pnpbp.2007.05.001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"1767_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/1534735410370036","volume":"9","author":"CF Jehn","year":"2010","unstructured":"Jehn CF, Kuhnhardt D, Bartholomae A, Pfeiffer S, Schmid P, Possinger K, Flath BC, Luftner D (2010) Association of IL-6, hypothalamus\u2013pituitary\u2013adrenal axis function, and depression in patients with cancer. Integr Cancer Ther 9(3):270\u2013275. doi: 10.1177\/1534735410370036","journal-title":"Integr Cancer Ther"},{"issue":"29","key":"1767_CR26","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2007.14.1978","volume":"26","author":"SK Lutgendorf","year":"2008","unstructured":"Lutgendorf SK, Weinrib AZ, Penedo F, Russell D, DeGeest K, Costanzo ES, Henderson PJ, Sephton SE, Rohleder N, Lucci JA 3rd, Cole S, Sood AK, Lubaroff DM (2008) Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol 26(29):4820\u20134827. doi: 10.1200\/JCO.2007.14.1978","journal-title":"J Clin Oncol"},{"issue":"2","key":"1767_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpainsymman.2007.03.009","volume":"35","author":"M Inagaki","year":"2008","unstructured":"Inagaki M, Isono M, Okuyama T, Sugawara Y, Akechi T, Akizuki N, Fujimori M, Mizuno M, Shima Y, Kinoshita H, Uchitomi Y (2008) Plasma interleukin-6 and fatigue in terminally ill cancer patients. J Pain Symptom Manage 35(2):153\u2013161. doi: 10.1016\/j.jpainsymman.2007.03.009","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1767_CR28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0269216311406991","volume":"26","author":"SM Kwak","year":"2012","unstructured":"Kwak SM, Choi YS, Yoon HM, Kim DG, Song SH, Lee YJ, Yeom CH, Koh SJ, Park J, Lee MA, Suh SY (2012) The relationship between interleukin-6, tumor necrosis factor-alpha, and fatigue in terminally ill cancer patients. Palliat Med 26(3):275\u2013282. doi: 10.1177\/0269216311406991","journal-title":"Palliat Med"},{"issue":"10","key":"1767_CR29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/pon.1122","volume":"16","author":"T Akechi","year":"2007","unstructured":"Akechi T, Okuyama T, Akizuki N, Shimizu K, Inagaki M, Fujimori M, Shima Y, Furukawa TA, Uchitomi Y (2007) Associated and predictive factors of sleep disturbance in advanced cancer patients. Psychooncology 16(10):888\u2013894. doi: 10.1002\/pon.1122","journal-title":"Psychooncology"},{"issue":"10","key":"1767_CR30","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1200\/JCO.2004.08.149","volume":"22","author":"T Akechi","year":"2004","unstructured":"Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y (2004) Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol 22(10):1957\u20131965. doi: 10.1200\/JCO.2004.08.149","journal-title":"J Clin Oncol"},{"issue":"1","key":"1767_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jpainsymman.2005.05.016","volume":"31","author":"T Akechi","year":"2006","unstructured":"Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA, Uchitomi Y (2006) Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage 31(1):5\u201312. doi: 10.1016\/j.jpainsymman.2005.05.016","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1767_CR32","first-page":"189","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res"},{"key":"1767_CR33","unstructured":"Mori E, Mitani Y, Yamadori A (1985) Usefulness of a Japanese version of the Mini-Mental State in neurological patients. Shinkeishinrigaku 1(82\u201390)"},{"key":"1767_CR34","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), clinician version","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), clinician version. American Psychiatric Press, Washington"},{"key":"1767_CR35","first-page":"371","volume":"4","author":"T Kitamura","year":"1993","unstructured":"Kitamura T (1993) Hospital Anxiety and Depression Scale (in Japanese). Seisinka Sindangaku 4:371\u2013372","journal-title":"Seisinka Sindangaku"},{"issue":"5","key":"1767_CR36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jjco\/28.5.333","volume":"28","author":"A Kugaya","year":"1998","unstructured":"Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y (1998) Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol 28(5):333\u2013338","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"1767_CR37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"1767_CR38","volume-title":"Handbook of studies on general hospital psychiatry","author":"FK Judd","year":"1991","unstructured":"Judd FK, Burrows GD, Lipsitt DR (1991) Handbook of studies on general hospital psychiatry. Elsevier, New York"},{"key":"1767_CR39","volume-title":"Guidance for industry, bioanalytical method validation","author":"Food and Drug Administration","year":"2001","unstructured":"Food and Drug Administration (2001) Guidance for industry, bioanalytical method validation. Food and Drug Administration, Washington"},{"issue":"1","key":"1767_CR40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.psy.49.1.64","volume":"49","author":"CM Jacobson","year":"2008","unstructured":"Jacobson CM, Rosenfeld B, Pessin H, Breitbart W (2008) Depression and IL-6 blood plasma concentrations in advanced cancer patients. Psychosomatics 49(1):64\u201366. doi: 10.1176\/appi.psy.49.1.64","journal-title":"Psychosomatics"},{"issue":"1","key":"1767_CR41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.110617","volume":"39","author":"K Fragiadaki","year":"2012","unstructured":"Fragiadaki K, Tektonidou MG, Konsta M, Chrousos GP, Sfikakis PP (2012) Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol 39(1):60\u201362. doi: 10.3899\/jrheum.110617","journal-title":"J Rheumatol"},{"issue":"5","key":"1767_CR42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/ard.2010.139725","volume":"70","author":"GR Burmester","year":"2011","unstructured":"Burmester GR, Feist E, Kellner H, Braun J, Iking-Konert C, Rubbert-Roth A (2011) Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24\u00a0weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA). Ann Rheum Dis 70(5):755\u2013759. doi: 10.1136\/ard.2010.139725","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1767_CR43","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T (2005) Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106(8):2627\u20132632. doi: 10.1182\/blood-2004-12-4602","journal-title":"Blood"},{"issue":"2","key":"1767_CR44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130(2):226\u2013238. doi: 10.1016\/j.pharmthera.2011.01.014","journal-title":"Pharmacol Ther"},{"key":"1767_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jncimonographs\/lgh023","volume":"32","author":"C Miaskowski","year":"2004","unstructured":"Miaskowski C, Dodd M, Lee K (2004) Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 32:17\u201321. doi: 10.1093\/jncimonographs\/lgh023","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"1767_CR46","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1188\/08.ONF.802-807","volume":"35","author":"JS Myers","year":"2008","unstructured":"Myers JS (2008) Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol Nurs Forum 35(5):802\u2013807. doi: 10.1188\/08.ONF.802-807","journal-title":"Oncol Nurs Forum"},{"issue":"8","key":"1767_CR47","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.112.103879","volume":"126","author":"M Hamer","year":"2012","unstructured":"Hamer M, Sabia S, Batty GD, Shipley MJ, Tabak AG, Singh-Manoux A, Kivimaki M (2012) Physical activity and inflammatory markers over 10\u00a0years: follow-up in men and women from the Whitehall II cohort study. Circulation 126(8):928\u2013933. doi: 10.1161\/CIRCULATIONAHA.112.103879","journal-title":"Circulation"},{"key":"1767_CR48","doi-asserted-by":"crossref","unstructured":"Almada C, Cataldo LR, Smalley SV, Diaz E, Serrano A, Hodgson MI, Santos JL (2012) Plasma levels of interleukin-6 and interleukin-18 after an acute physical exercise: relation with post-exercise energy intake in twins. J Physiol Biochem. doi: 10.1007\/s13105-012-0191-x","DOI":"10.1007\/s13105-012-0191-x"},{"issue":"2","key":"1767_CR49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cyto.2009.05.011","volume":"47","author":"SR Gray","year":"2009","unstructured":"Gray SR, Clifford M, Lancaster R, Leggate M, Davies M, Nimmo MA (2009) The response of circulating levels of the interleukin-6\/interleukin-6 receptor complex to exercise in young men. Cytokine 47(2):98\u2013102. doi: 10.1016\/j.cyto.2009.05.011","journal-title":"Cytokine"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-013-1767-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-013-1767-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T04:30:09Z","timestamp":1562733009000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-013-1767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1007\/s00520-013-1767-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}